Anti-SARS-CoV-2 Activity of Polysaccharides Extracted from Halymenia floresii and Solieria chordalis (Rhodophyta)
Marine Drugs · 06.06.2023 · 21 (6) · 348
DOI: 10.3390/md21060348 ↗Kurz gefasst
Fachartikel in der Zeitschrift Marine Drugs, online erschienen am 06.06.2023. Verfasst von Clément Jousselin und 7 weiteren Autor:innen. Beteiligte Einrichtung: Laboratoire de Virologie et Mycobactériologie, Centre Hospitalier Universitaire, 86021 Poitiers, France. Hauptthemen laut MEDLINE: COVID-19, Rhodophyta. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Secretariat of Public Education, Secretaría de Educación, Ciencia, Tecnología e Innovación de la Ciudad de México, Laboratoire de Biotechnologie et Chimie Marines (LBCM), Université Bretagne Sud (UBS).
Abstract (Originalsprache)
Even after hundreds of clinical trials, the search for new antivirals to treat COVID-19 is still relevant. Carrageenans are seaweed sulfated polysaccharides displaying antiviral activity against a wide range of respiratory viruses. The objective of this work was to study the antiviral properties of Halymenia floresii and Solieria chordalis carrageenans against SARS-CoV-2. Six polysaccharide fractions obtained from H. floresii and S. chordalis by Enzyme-Assisted Extraction (EAE) or Hot Water Extraction (HWE) were tested. The effect of carrageenan on viral replication was assessed during infection of human airway epithelial cells with a clinical strain of SARS-CoV-2. The addition of carrageenans at different times of the infection helped to determine their mechanism of antiviral action. The four polysaccharide fractions isolated from H. floresii displayed antiviral properties while the S. chordalis fractions did not. EAE-purified fractions caused a stronger reduction in viral RNA concentration. Their antiviral action is likely related to an inhibition of the virus attachment to the cell surface. This study confirms that carrageenans could be used as first-line treatment in the respiratory mucosa to inhibit the infection and transmission of SARS-CoV-2. Low production costs, low cytotoxicity, and a broad spectrum of antiviral properties constitute the main strengths of these natural molecules.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratoire de Virologie et Mycobactériologie, Centre Hospitalier Universitaire, 86021 Poitiers, France.
- Laboratoire Inflammation Tissus Epitheliaux et Cytokines, Université de Poitiers, 86073 Poitiers, France.
- Université Bretagne-Sud, EMR CNRS 6076, LBCM, IUEM, F-56000 Vannes, France.
- Centro de Investigación y de Estudios Avanzados (CINVESTAV), Unidad Mérida, AP 73, Cordemex, Mérida 97310, Yucatán, Mexico.
ORCID-Profile: Hugo Pliego-Cortés, Charles Bodet, Daniel Robledo, Nathalie Bourgougnon
Förderung
- Secretariat of Public Education
- Secretaría de Educación, Ciencia, Tecnología e Innovación de la Ciudad de México
- Laboratoire de Biotechnologie et Chimie Marines (LBCM), Université Bretagne Sud (UBS)
Zitieren
APA
Jousselin, C., Pliego-Cortés, H., Damour, A., Garcia, M., Bodet, C., Robledo, D., Bourgougnon, N., & Lévêque, N. (2023). Anti-SARS-CoV-2 Activity of Polysaccharides Extracted from Halymenia floresii and Solieria chordalis (Rhodophyta). Marine Drugs, 21(6), 348. https://doi.org/10.3390/md21060348
Vancouver
Jousselin C, Pliego-Cortés H, Damour A, Garcia M, Bodet C, Robledo D, et al. Anti-SARS-CoV-2 Activity of Polysaccharides Extracted from Halymenia floresii and Solieria chordalis (Rhodophyta). Marine Drugs. 2023;21(6):348. doi:10.3390/md21060348
BibTeX
@article{Jousselin2023,
author = {Jousselin, Clément and Pliego-Cortés, Hugo and Damour, Alexia and Garcia, Magali and Bodet, Charles and Robledo, Daniel and Bourgougnon, Nathalie and Lévêque, Nicolas},
title = {Anti-SARS-CoV-2 Activity of Polysaccharides Extracted from Halymenia floresii and Solieria chordalis (Rhodophyta)},
journal = {Marine Drugs},
year = {2023},
volume = {21},
number = {6},
pages = {348},
doi = {10.3390/md21060348}
}
EUVIMED